高级检索
当前位置: 首页 > 详情页

A functional variant at miRNA-122 binding site in IL-1α 3′ UTR predicts risk and HPV-positive tumours of oropharyngeal cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Key Lab Otolaryngol Head & Neck Surg, Dept Otolaryngol Head & Neck Surg, Beijing Tongren Hosp,Minist Educ,Beijing Inst Oto, Beijing 100730, Peoples R China [2]Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA [3]Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA [4]Qingdao Univ, Yuhuangding Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Yantai, Peoples R China [5]Tumor Hosp Yunnan Prov, Dept Head & Neck Surg, Kunming 650118, Peoples R China [6]Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA
出处:
ISSN:

关键词: IL-1 alpha variant HPV Oral cancer SCCOP Cancer risk Biomarker miRNA

摘要:
Background: Genetic polymorphisms in the 3' untranslated regions (3' UTRs) targeted by miRNAs alter the strength of miRNA binding in a manner that affects the behaviour of individual miRNAs. An insertion (Ins)/deletion (Del) polymorphism (rs3783553) in the 3' UTR of IL-1 alpha may disrupt a binding site for miRNA-122. IL-1 alpha plays an important role in inflammation, immunity and defense against infection. Thus, we hypothesised that the rs3783553 polymorphism affects individual susceptibility to human papillomavirus (HPV)-associated oral squamous cell carcinoma (OSCC). Methods: We genotyped the rs3783553 polymorphism; and determined HPV16 L1 serology, tumour HPV16 DNA and serum IL-1 alpha expression. Univariate/multivariable logistic regression models were used to calculate associations. Results: We found that HPV16 L1 seropositivity alone was associated with an increased risk of OSCC (Odds ratio (OR), 3.1; 95% confidence interval (CI), 2.1-4.6), and the risk of HPV16-associated OSCC was modified by the rs3783553 polymorphism. Patients with both HPV16 L1 seropositivity and Del/Del genotype for the rs3783553 had the highest risk of OSCC when using patients with HPV16 L1 seronegativity and Ins/Del + Ins/Ins genotypes as a comparison group. Notably, that effect modification was particularly pronounced in several subgroups (e.g. SCCOP, never-smokers and never-drinkers). The patients with Del/Del genotype were approximately 3.0 times more likely to have HPV16-positive squamous cell carcinoma of the oropharynx (SCCOP) tumours compared to those patients with Ins/Del + Ins/Ins genotypes. Additionally, functional relevance of this variant was characterised to explore the genotype-phenotype correlation. Conclusion: These results suggest that IL-1 alpha 3' UTR rs3783553 polymorphism may be functional and influence susceptibility to HPV16-associated OSCC, particularly for SCCOP. Validation of our findings is warranted. (C) 2015 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2013]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Capital Med Univ, Key Lab Otolaryngol Head & Neck Surg, Dept Otolaryngol Head & Neck Surg, Beijing Tongren Hosp,Minist Educ,Beijing Inst Oto, Beijing 100730, Peoples R China [2]Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
共同第一作者:
通讯作者:
通讯机构: [1]Capital Med Univ, Key Lab Otolaryngol Head & Neck Surg, Dept Otolaryngol Head & Neck Surg, Beijing Tongren Hosp,Minist Educ,Beijing Inst Oto, Beijing 100730, Peoples R China [2]Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA [3]Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA [*1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck, Surg, Beijing 100730, Peoples R China [*2]Department of Head and Neck Surgery, Unit 1445, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25477 今日访问量:0 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)